The new module enables one-step reverse transcription and amplification, removing cDNA prep and supporting applications in translational research, cell and gene therapy manufacturing, and diagnostic development.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
Faster, more accurate testing is helping clinicians identify synthetic opioids sooner and treat overdoses more effectively.
The 24- and 48-format carriers join the existing 96-format solution to provide laboratories with scalable tube processing workflows.
Circulating tumor DNA testing can identify stage 3 patients who may safely receive reduced treatment intensity, international study finds.
